These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1162990)

  • 21. [Analysis of the effects of prevention of threatened abortion and premature labor with intravenous and oral preparation, Partusisten].
    Swiderski R; Bak-Dzierzyński A; Piróg L; Zdebski Z; Niespodziański K
    Ginekol Pol; 1978 Jul; 49(7):621-4. PubMed ID: 710954
    [No Abstract]   [Full Text] [Related]  

  • 22. [Administration of Partusisten in imminent premature labor].
    Dzioba A; Baranowski H; Szacki J; Smulikowski A; Riess A
    Wiad Lek; 1975 Aug; 28(15):1275-80. PubMed ID: 1163004
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical trial of Magnerot in the treatment of a threatened abortion after a previous delivery].
    Kavardzhikova S
    Akush Ginekol (Sofiia); 2000; 40(4):54-5. PubMed ID: 11288641
    [No Abstract]   [Full Text] [Related]  

  • 24. [A new long-acting Partusisten preparation for oral tocolysis--results of a multicenter study].
    Rausch K; Hermer M; Brehm H; Edwabny V; Lang N
    Z Geburtshilfe Perinatol; 1984; 188(4):185-90. PubMed ID: 6385511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the effectiveness of partusisten for prevention of premature labor].
    Biczysko R; Słomko Z; Cwojdziński Z; Zaremba Z
    Ginekol Pol; 1980 Apr; 51(4):355-8. PubMed ID: 6993303
    [No Abstract]   [Full Text] [Related]  

  • 26. [1st impressions of the obstetrical effect of the drug Partusisten (preliminary report)].
    Shturkalev I; Karaguozov E; Kiutukchiev B; Atanasov D; Krutilin S
    Akush Ginekol (Sofiia); 1976; 15(5):341-6. PubMed ID: 13672
    [No Abstract]   [Full Text] [Related]  

  • 27. Fenoterol: an effective agent for the postponement of preterm birth.
    TambyRaja RL; Ng SC; Ratnam SS
    N Z Med J; 1981 Apr; 93(681):218-20. PubMed ID: 7017512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tocolytic substituent treatment with Magnerot in threatened abortions and premature labor from the 16th to the 36th gestational week].
    Damianov L; Negentsov N; Ivanov S; Novachkov V; Tsachev K
    Akush Ginekol (Sofiia); 1995; 34(3):78-81. PubMed ID: 8743863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Possible applications of partusisten in obstetrics].
    Khadzhiev A; Markovski N; Iordanov G; Ruseva R; Marinov B
    Akush Ginekol (Sofiia); 1983; 22(2):151-5. PubMed ID: 6638388
    [No Abstract]   [Full Text] [Related]  

  • 30. [Partusisten and sigetin treatment of hypotrophy of female rabbit fetuses in experimental disorders of utero-placental circulation].
    Chistiakov GV
    Vestn Akad Med Nauk SSSR; 1981; (6):36-8. PubMed ID: 6117162
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of uterine dystocia during labor with the aid of Partusisten].
    Soszka S; Krawczuk A; Sipowicz I; Urban J; Poznanski J
    Ginekol Pol; 1979 May; 50(5):427-30. PubMed ID: 468059
    [No Abstract]   [Full Text] [Related]  

  • 32. [Monitoring changes in the heart rate of the premature fetus during tocolysis with the beta-adrenomimetics partusisten and Pre-par].
    Ivanov S; Tsankov TS
    Akush Ginekol (Sofiia); 1985; 24(1):36-9. PubMed ID: 4040339
    [No Abstract]   [Full Text] [Related]  

  • 33. [Properties of chromatin of peripheral blood lymphocytes in women with threatened abortion].
    Tolmachev VS; Borovitskaia EI; Semchenkova SA; Kushch AA; Zelenin AV
    Biull Eksp Biol Med; 1984 Feb; 97(2):181-3. PubMed ID: 6696985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monitoring changes in the reactivity of the premature fetus during tocolysis with the beta-adrenomimetics Partusisten and Pre-par].
    Ivanov S; Tsankov Ts
    Akush Ginekol (Sofiia); 1985; 24(2):34-6. PubMed ID: 4014600
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dynamic changes in the frequency of the uterine contractions during tocolysis with the beta-adrenomimetic Partusisten in high rupture of the amniotic sac].
    Ivanov S
    Akush Ginekol (Sofiia); 1984; 23(1):42-5. PubMed ID: 6721114
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis of the correlation between the dose-response curve for prostaglandin F2alpha and the progress of pregnancy, cervix ripening, pharmacologic estrogen premedication and Partusisten administration in prostaglandin-induced labor].
    Czekanowski R; Kuźniar B
    Zentralbl Gynakol; 1985; 107(2):79-83. PubMed ID: 3857830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the effects of chlormadinone in the treatment of threatened abortion].
    Cárdenas J
    Ginecol Obstet Mex; 1973 Jan; 33(195):121-4. PubMed ID: 4121383
    [No Abstract]   [Full Text] [Related]  

  • 38. Intrauterine hematoma: a prognostic enigma in threatened abortion.
    Raymond FR; Dono FV; Thomas RJ
    J Am Osteopath Assoc; 1985 Jan; 85(1):27-32. PubMed ID: 3881372
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of Salbutamol in obstetrics].
    Dellenbach P; Vors J
    Therapeutique; 1972 Dec; 48(10):671-5. PubMed ID: 4145202
    [No Abstract]   [Full Text] [Related]  

  • 40. [Monitoring changes in the variability of the heart rate of the preterm fetus during tocolysis with beta-adrenomimetics. Partusisten and Pre-par].
    Ivanov S
    Akush Ginekol (Sofiia); 1983; 22(5):365-7. PubMed ID: 6675476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.